Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 4397  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
  » Next article
  » Previous article 
  » Table of Contents
 Resource Links
  »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
  »  Article in PDF (95 KB)
  »  Citation Manager
  »  Access Statistics
  »  Reader Comments
  »  Email Alert *
  »  Add to My List *
* Registration required (free)  

  In this Article
 »  Abstract
 »  Introduction
 »  Materials and Me...
 »  Results
 »  Discussion
 »  References
 »  Article Tables

 Article Access Statistics
    PDF Downloaded414    
    Comments [Add]    
    Cited by others 67    

Recommend this journal


Year : 2005  |  Volume : 53  |  Issue : 1  |  Page : 46-50

Frequent seizures and polytherapy can impair quality of life in persons with epilepsy

1 Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India
2 College of Pharmaceutical Sciences, Medical College, Trivandrum, India

Date of Acceptance11-Dec-2004

Correspondence Address:
Sanjeev V Thomas
R. Madhavan Nair Center for Comprehensive Epilepsy Care, SCTIMST, Trivandrum - 695 011, Kerala
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0028-3886.15054

Rights and Permissions

 » Abstract 

CONTEXT: Careful evaluation of pharmacotherapy, seizure control and quality of life (QOL) are helpful in improving epilepsy care but such data are relatively meager from developing countries. AIMS: To audit pharmacotherapy, seizure control and QOL in persons with epilepsy and to identify factors associated with impaired QOL. SETTINGS AND DESIGN AND MATERIALS AND METHODS: The study was carried out using a cross-sectional design in the setting of a tertiary care epilepsy center in India. Persons with epilepsy with >12 months follow-up at this Center and aged >16 years were eligible for enrollment. Persons with other disabilities or pregnancy were excluded. Subjects were interviewed with a standard questionnaire and an adapted version of Quality of Life in Epilepsy - 31 (QOLIE-31). Data pertaining to treatment at the time of referral to this center was extracted from medical records. STATISTICAL ANALYSIS USED: Chi-square test, analysis of variance and multiple regression analysis were carried out for statistical significance. RESULTS: One hundred and twelve patients with epilepsy (59 males, mean age 31.2±10.7 years) were included. Forty-seven (42%) persons had Generalized Epilepsy (GE) and 65 persons (58%) had Localization-Related Epilepsy (LRE). At entry 24 persons (21.4%) were not on treatment and 59 persons (64.8%) had frequent seizures. At last follow-up 64 persons (57.1%) were seizure-free, 83 persons (74.1%) were on monotherapy and 29 were (25.9%) on polytherapy. Cost of drug at entry was INR 2276 (monotherapy) and INR 3629 (polytherapy) (45 INR = 1 USD). At the time of last follow-up, it was 1898 and 4929 respectively. QOLIE-31 Total Score (TQOL) ranged from 22.6 to 94.4 (mean 68.0 ± 15.8). Multiple regression analysis showed significant correlation between low TQOL score and polytherapy (P=0.002) and occurrence of one or more seizures per month (P=0.001). CONCLUSIONS: Frequent seizures and polytherapy are associated with lower QOL in persons with epilepsy.

Keywords: Quality of life, cost, pharmacotherapy, seizure control

How to cite this article:
Thomas SV, Koshy S, Sudhakaran Nair C R, Sarma SP. Frequent seizures and polytherapy can impair quality of life in persons with epilepsy. Neurol India 2005;53:46-50

How to cite this URL:
Thomas SV, Koshy S, Sudhakaran Nair C R, Sarma SP. Frequent seizures and polytherapy can impair quality of life in persons with epilepsy. Neurol India [serial online] 2005 [cited 2022 Dec 8];53:46-50. Available from: https://www.neurologyindia.com/text.asp?2005/53/1/46/15054

 » Introduction Top

World Health Organization and the International League against Epilepsy have estimated that 34 million out of 40 million people with epilepsy in the world live in developing countries and nearly 80% of them are not on treatment. The paucity of medical infrastructure, poor affordability, and certain social or cultural beliefs interfere with optimal care for epilepsy in these countries. The benefit of treatment is commonly measured from a caregiver's perspective that often includes seizure frequency, occurrence of adverse effects and other laboratory measures. The impact of epilepsy on the life of the patient, particularly in the psychosocial realm is not adequately represented in such estimates. Recently, Quality of life (QOL) measures have been included to supplement other outcome measures with the patient's perspective also. QOL evaluation in epilepsy passed through several phases before it reached the current concepts.[1] Several tools have been developed to estimate QOL in epilepsy in different settings such as drug trials, epilepsy surgery programs and for general purposes such as QOLIE-31,[2] Epilepsy Surgery Inventory (ESI-55)[3] and Short form- 36(SF-36)[4] respectively. The treatment of epilepsy vis-à-vis QOL has not been adequately audited in developing countries. The main objective of this study was to audit the pharmacotherapy, seizure frequency and QOL in the setting of a referral hospital in a developing country. The other objective of this study was to ascertain any association between QOL and demographic characteristics (such as sex, age, occupation), disease characteristics (such as type of epilepsy, duration, seizure frequency) and pharmacotherapy characteristics (monotherapy vs. polytherapy, type of Anti-Epileptic Drug (AED) used and occurrence of adverse drug reactions (ADR)).

 » Materials and Methods Top

This study was carried out at the R. Madhavan Nair Center for Comprehensive Epilepsy Care in Sree Chitra Tirunal Institute, Trivandrum, Kerala, India. We accept patients only on referral from peripheral centers (any medical practitioner or clinic). Approximately 800 to 900 persons with epilepsy are enrolled in this center every year and about 60 persons with medically refractory epilepsy are operated every year with a 65-80% success rate. Some 80 to 100 patients with epilepsy are reviewed every week in the two clinics attached to this center. Consecutive outpatients attending the epilepsy clinics of this Center between August and October 2003 were considered for possible inclusion in this study. Only those persons with definite diagnosis of epilepsy, age more than 16 years and follow-up in this Center for 12 months or more were eligible for inclusion. Terminology according to ILAE classification of seizures and epileptic syndromes[5] was followed. Pregnant women, persons who are not conversant with Malayalam language and persons with significant disabilities such as mental retardation, motor disability (cerebral palsy, hemiparesis, ataxia, etc) language disability, visual or hearing impairment, psychosis or other medical or surgical infirmity were excluded. Persons who were otherwise eligible but not willing to participate in the study due to lack of time or disinclination were also excluded. The study was carried out with the permission of the Institute. Informed consent was obtained from all persons. Details of clinical condition, seizure frequency and anti-epileptic drug (AED) status at the time of entry to this Center, were extracted from the medical records. At the time of last follow-up i.e. when the patients were enrolled and data were compiled, all subjects were administered a structured questionnaire regarding current seizure frequency, compliance with drug therapy, and a checklist for possible ADR. QOLIE-31 questionnaire was also administered at the same visit. Seizure burden was scored according to Engel system[6] that scores seizure frequency and disability on a quasi-logarithmic scale ranging from 0-12. Scores less than 5 indicate no seizures or non-disabling seizures (aura or brief partial seizures without impairment of consciousness or loss of muscular tone) only. Score 5 denotes 1 to 3 seizures per year; score 6 indicates 4-11 seizures per year. Seizure frequency of 1 per month and above is scored 7-12. Absence seizures and myoclonic seizures were not counted for the purpose of seizure frequency. Seizure freedom was defined as absence of disabling seizures for more than 12 months continuously.

We have recorded the dosage of AEDs as a ratio of Prescribed Daily Dosage to Daily Defined Dosage (PDD/DDD). PDD refers to the total dose per day prescribed for a given AED. WHO has defined the daily-defined dose of a drug (DDD) as the assumed average maintenance dose per day used for its main indication in a reference person of 70 kilograms body weight. The reference weight for a man and a woman in the Indian population, according to the Indian Council of Medical research (ICMR)[7] is 55 kg and 45 kg respectively. For the purpose of this study, we have taken the reference weight for a person as 50 kg and modified the DDD as given in [Table - 1]. We used the market price of AEDs to estimate cost. QOL was measured using adapted translation of QOLIE-31 2 that was in use in this Institution for several years. The original English version was translated into the local (Malayalam) language and accuracy was ascertained by back translation. We had adapted the QOLIE-31 to suit the local socio-cultural milieu by modifying some questions, for e.g. ability to drive was replaced by ability to travel independently. QOLIE-31 has one visual analogue scale of overall quality of life and 30 questions pertaining to diverse aspects of QOL. Each aspect, the number of questions under that aspect and the range score for that aspect were as follows: Seizure worry (5, 0-8), Overall quality of life (2, 0-14), Emotional well-being (5, 0-15), Energy or Fatigue (4, 0-12), Cognitive performance (6, 0-27), Medication effects (3, 0-3) and Social function (5, 0-21), Total score (30, 0-100). A lower score indicates poor quality of life and higher score indicates better quality of life. Chi-square test, ANOVA and multiple regression analysis were employed on SPSS package to ascertain statistical significance. P values less than 0.05 were taken as statistically significant.

 » Results Top

We studied 112 patients (59 males and 53 females) with epilepsy, mean age was 31.2 ±10.7 years (range 17-60 years). Mean age of onset of epilepsy was 17.5±9.9 years and mean age of initiation of AED therapy was 23.1±10.0 years. The epileptic syndrome was generalized epilepsy (GE) in 47 persons and localization-related epilepsy (LRE) in 65 persons. There were 20 students, 48 employed persons and 41 unemployed persons. Employment status was not ascertained for three persons.

At the time of entry to this Institute, 24 persons were not taking any AEDs for reasons including lack of therapeutic effectiveness, use of traditional medicines, adverse effects of medicines, recent onset of epilepsy, non-disabling nature of seizures and prohibitive cost of drugs. Treatment delay for those who were on AEDs was 3.0±3.0 years (range 0.08-12 years). The delay in treatment was attributed to the use of traditional medicines, non-disabling nature of seizures and different diagnosis. Details of pharmacotherapy at last follow-up in comparison to that at the time of entry is given in [Table - 2]. The drugs prescribed for GE were valproate (VPA) 36(76.6%), phenytoin (PHT) 6(12.8%), phenobarbitone (PB) 3(6.4%), carbamazepine (CBZ) 3(6.4%) and clonazepam (CZP) 2(4.3%), while those for LRE were CBZ 45(69.23%), clobazam (CLB) 15(23.1%), PHT 14(21.5%), PB 10(15.4%), VPA 4(6.2%) and CZP 1(1.5%). Combinations between primary drugs (CBZ, VPA, PHT and PB) decreased while combination of primary drug (mostly CBZ) and CLB increased [Table - 2] at the time of last follow-up when compared to entry to the referral center. The mean PDD/DDD ratios of most AEDs at the time of entry to the Center were lower than at the time of last follow-up [Table - 2]. On last follow-up, ADRs were recorded in 19 (16.9%) persons. They included drowsiness and memory impairment in three persons each, headache, gum hypertrophy, and weight gain in two each, and sedation, diplopia, tremor, dry skin, nausea, enuresis and eosinophilia in one patient each.

At the time of referral to this Center, none were seizure-free (Engel score < 5) and at last follow-up in this Center 64 persons were seizure-free [Table - 2]. Seizure control was significantly better (P=0.02) for persons with GE (68.1%) when compared to persons with LRE (49.2%).

Annual cost of AEDs for a person on monotherapy was INR 2276 at the time of entry to this Center. (Indian rupees, INR 45 = US Dollars, USD 1.) The annual cost of AEDs declined to INR 1898 at last follow-up at this Center whereas the annual cost for polytherapy increased from INR 3621 to INR 4929 per person. The annual cost of AEDs per person for monotherapy and polytherapy in this study was 8.8% and 22.8% respectively of the per capita Gross National Income (GNI). The per capita GNI for an Indian in 2002 was USD 480).[8]

QOLIE-31 scale total score (TQOL) ranged from 22.6 to 94.4 (mean 68.0 ± 15.8). The interquartile range was 21.8. Mean scores on QOLIE-31 subscales were seizure worry (5.5±2.2), emotional well-being (8.9±2.8), energy/fatigue (7.7±2.2), cognition (18.1±6.3), medication effects (1.8±0.9), social function (16.4±4.3). All subcomponents co-varied with the total score. Mean TQOL scores for demographic characteristics, type of epilepsy, seizure frequency and AED use are given in [Table - 3]. On analysis of variance, there was no significant association between TQOL and gender, age group and occupation of patients. Duration of epilepsy or any specific AEDs did not have any significant association with TQOL. Mean TQOL for LRE (65.4 + 18.1) was significantly lower (degree of freedom 110, 95% Confidence interval -12. to -0.45, P = 0.035) than that for GE (71.4 + 11.3). Patients who were on monotherapy had higher TQOL (70.8 + 14.9) when compared to those who were on polytherapy (60.2 + 16.0) which was statistically significant (degree of freedom 110, 95% Confidence Interval 4.07-17.07, P = 0.002). On analysis of variance, mean TQOL had a statistically significant association with seizure frequency [Table - 3]. A stepwise multiple regression analysis was carried out with the model including these factors as independent variables and TQOL as dependent variable. The model had an adjusted R2=0.147. The results revealed a statistically significant independent association between lower TQOL and polytherapy (standardized beta -0.196, P=0.041) and Engel score of seizure frequency >6 (standardized beta -0.281, P=0.003).

 » Discussion Top

The salient observations in this study were that at the time of entry to the study, the treatment gap was around 21%, more patients were experiencing frequent seizures despite use of polytherapy and overall cost of treatment was high. At the time of last follow-up in this center, fewer patients were on polytherapy, seizure control was better and overall cost of treatment was lower. Frequent seizures and use of polytherapy were independently associated with lower total score on QOLIE-31 scale of QOL.

Limited resources and higher treatment gaps characterize epilepsy care in developing countries.[9] In this study, we have focused on pharmacotherapy profile, seizure control and QOL for a cohort of persons with epilepsy attending a tertiary referral epilepsy center in a developing country. This particular setting had enabled us to examine the pharmacotherapy of epilepsy in this advanced care center in comparison to the peripheral centers from where the patients were referred to us. The absence of QOLIE-31 evaluation at the time of entry to the center and the absence of formal psychological profiling are the two limitations of this study. The AED profile at the time of entry to this referral center for epilepsy reflects the prescribing practices prevailing in the peripheral centers. The prevailing scenario when patients are referred from peripheral centers is characterized by usage of relatively low dosages (PDD/DDD <1) of AEDs, polytherapy and high seizure frequency. It appeared that in peripheral centers polytherapy was adopted more readily rather than prescribing higher doses of monotherapy, when confronted with poor control of seizures.

Nearly a quarter of persons were not on treatment at the time of referral (entry to this Center). Treatment gap in developing countries in general is high, to the tune of 80%.[9] The treatment gap in this study was much lower (21.4%) but was comparable to that observed in a community study (38%) carried out in same state.[10] Higher educational and general health standards prevailing in the Kerala State in India could possibly be one of the reasons for the relatively lower treatment gap found in this study as well as the previous study. Reasons for the treatment gap for persons referred to tertiary epilepsy centers (lack of therapeutic effectiveness, use of traditional medicines, adverse effects of medicines, recent onset of epilepsy, non-disabling nature of seizures and prohibitive cost of drugs) are different from those observed in epidemiological studies (lack of prioritization, poor infrastructure, cost and supply of AEDs and different perceptions of the disease in different countries).[9]

In this study we observed that monotherapy is probably underutilized in the peripheral centers. Similar observations were made in an earlier study also.[11] In the present study several persons were shifted to sodium valproate therapy after a diagnosis of GE was confirmed. Such practices have been documented elsewhere also.[12],[13] WHO had recommended PB as the first-line drug,[14] a policy that appears to be largely influenced by economic reasons. PB is widely used in India. Two earlier studies from India[15],[16] have shown that epilepsy can be successfully treated with PB or PHT with no excess adverse effects. PB may have a limited role in LRE particularly when seizures have become medically intractable. The proportion of patients on polytherapy had decreased at the time of the last follow-up. The pattern of polytherapy practiced in this referral center (combination of CBZ and CLB) differed from that followed in peripheral centers (combinations between CBZ, VPA, PHT, and PB). This shift in polytherapy practice probably reflects the recent trend for rational polytherapy.[17] The frequency of polytherapy in this study is comparable with other referral centers in India.[18] Polytherapy is generally reserved for refractory seizures largely due to LRE. ADR were observed only in 16.9% of the persons at last follow-up, which was comparable with earlier observations.[11]

The cost of drugs is an important factor in developing countries, since it constitutes 57% of the total direct cost.[19] The annual cost of AEDs for monotherapy, in this study, was about 9% of GNI per capita and increased two and a half times if a person was on polytherapy. The price of the drugs influences the prescription pattern in India to a large extent because such expenditure is borne by the patient and his family in the majority of instances. One of the reasons for treatment gap in this study was the prohibitive cost of drugs.

The quality of life evaluation is a relatively new measure to evaluate the outcome of treatment for epilepsy. QOL is influenced by biological factors as well as cultural, social and religious beliefs and values. We evaluated QOL with QOLIE-31, an instrument that covers several domains with reference to a specific time period. This is the first report on QOL from India. The QOLIE-31 was adapted for the Indian social milieu. In this study the TQOL ranged from 22.6 to 94.4 but the mean was 68.0 (SD 15.8). In the earlier studies several factors have been identified to correlate significantly with QOL; seizure frequency,[20],[21],[22] presence of adverse effects,[23] female gender,[20] low educational status and psychosocial factors are some of them.[20],[24] In our series only three factors - LRE, seizure frequency of one or more per month, and polytherapy- were associated with lower TQOL on ANOVA. Use of PB was associated with marginally lower cognition score but did not have statistical significance. Multiple regressions with these factors included in the model, identified frequent seizures and polytherapy to be independently associated with lower TQOL scores. In contrast to some of the earlier reports, gender, educational status and presence of ADR did not have any significant association with TQOL in this study. This protocol did not allow for any correlation between TQOL and psychological factors, since such data were not collected. Our observation that frequent seizures and polytherapy have significant association with QOL emphasizes the pivotal role of these two aspects in epilepsy care. QOL estimate is a useful outcome measure to assess epilepsy care from a patient's perspective. It is relatively easy to give out simple self-administered QOL instruments like QOLIE-31 even in busy epilepsy clinics in developing countries. The management of a person with epilepsy should focus on better control of seizures with appropriate use of AEDs, preferably monotherapy, which would improve quality of life.

 » References Top

1.Hermann BP. The evolution of health related quality of life assessment in epilepsy. Qual Life Res 1995;4:87-100.  Back to cited text no. 1  [PUBMED]  
2.Cramer JA, Perrine K, Devinsky O, Bryant-Comstock L, Meador K, Hermann B. Development and cross cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia 1998;39:81-8.  Back to cited text no. 2  [PUBMED]  
3.Vickrey BG, Hays RD, Graber J, Rausch R, Engel J Jr, Brook RH. A health related quality of life instrument for patients evaluated for epilepsy surgery. Med Care 1992;30:299-319.  Back to cited text no. 3  [PUBMED]  
4.Ware JE Jr, Sherbourne CD. The MOS 36 - item short form health survey (SF-36). Conceptual framework and item selection. Med Care 1992;30:473-83.  Back to cited text no. 4  [PUBMED]  
5.Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99.  Back to cited text no. 5  [PUBMED]  
6.Engel J Jr, Ness V, Rasmussen, Ojemann LM. Outcome with respect to epileptic seizures. In: Surgical treatment of the epilepsies (Ed Engel J Jr). New York: Raven Press; 1993. p. 609-22.  Back to cited text no. 6    
7.Antia FP. Clinical dietetics and nutrition. 3rd Ed. New York: Oxford University Press; 1989.  Back to cited text no. 7    
8.World development report. New York: Oxford University Press; 2004. p. 252.  Back to cited text no. 8    
9.Scott RA, Lhatoo SD, Sander JWAS. The treatment of epilepsy in developing countries: Where do we go from here? Bulletin of the World Health Organization 2001;79:344-51.  Back to cited text no. 9    
10.Radhakrishnan K, Pandian JP, Santhoshkumar T, Thomas SV, Deetha TP, Sarma PS, et al. Prevalence, knowledge, attitude and practice of epilepsy in Kerala and India. Epilepsia 2000;41:1027-35.  Back to cited text no. 10    
11.Radhakrishnan K, Nayak PS, Kumar SP, Sarma PS. Profile of antiepileptic pharmacotherapy in a tertiary referral centre in South India: A pharmacoepidemiologic and pharmacoeconomic study. Epilepsia 1999;40:179-85.  Back to cited text no. 11    
12.Kleveland G, Engelsen BA. Juvenile myoclonic epilepsy: Clinical characteristics, treatment and prognosis in a Norwegian population of patients. Seizure 1998;7:31-8.  Back to cited text no. 12  [PUBMED]  
13.Atkali D, Sozuer D, Atay T, Baybas S, Arpaci B. Misdiagnosis and treatment in juvenile myoclonic epilepsy. Seizure 1998;7:63-6.  Back to cited text no. 13    
14.World Health Organization. Initiative of support to people with epilepsy. Geneva: World Health Organization; 1990.  Back to cited text no. 14    
15.Mani KS, Rangan G, Srinivas HV, Srindharan VS, Subbakrishna DK. Epilepsy control with Phenobarbital or phenytoin in rural South India: The Yelandur study. Lancet 2001;357:1316-20.  Back to cited text no. 15  [PUBMED]  [FULLTEXT]
16.Pal DK, Das T, Chaudhury G, Johnson AL, Neville BG. Randomised controlled trial to assess acceptability of Phenobarbital for childhood epilepsy in rural India. Lancet 1998;351:19-23.  Back to cited text no. 16  [PUBMED]  [FULLTEXT]
17.Perucca E. Current trends in antiepilepstic drug therapy. Epilepsia 2003;44:41-7.  Back to cited text no. 17  [PUBMED]  
18.Thomas SV, Sarma PS, Alexander M, Pandit L, Shekhar L, Trivedi C, et al. Epilepsy care in six Indian cities: A multistudy on management and service. J Neurol Sci 2001;188:73-7.  Back to cited text no. 18  [PUBMED]  [FULLTEXT]
19.Thomas SV, Sarma PS, Alexander M, Pandit L, Shekhar L, Trivedi C, et al. Economic burden of epilepsy in India. Epilepsia 2001;42:1052-60.  Back to cited text no. 19  [PUBMED]  [FULLTEXT]
20.Shakarishvilli DM. Influence of clinical, demographic and socioeconomic variables on QOL in patients with epilepsy: Findings from Georgian study. J Neurol Neurosurg Psychiatry 2003;74:570-73.  Back to cited text no. 20    
21.Leidy NK, Elixhauser A, Vickrtey B, Means E, William MK. Seizure frequency and the health related quality of life of adults with epilepsy. Neurology 1999;53:162-6.  Back to cited text no. 21    
22.Haut BV, Gagnon D, Soutre E, Reid S, Remy C, Baker G, et al. Relationship between seizure frequency and costs and quality of life of outpatients with partial epilepsy in France, Germany and the United Kingdom. Epilepsia 1997;38:1221-6.  Back to cited text no. 22    
23.Baker G, Jacoby A, Buck D, Stalgis C, Monnet D. Quality of life of people with epilepsy: A European study. Epilepsia 1997;38:353-62.  Back to cited text no. 23    
24.Choi-Kwon S, Chung C, Kim H, Lee S, Yoon S, Kho H, et al. Factors affecting the quality of life in patients with epilepsy in Seol, South Korea. Acta Neurol Scand 2003;108:428-34.  Back to cited text no. 24  [PUBMED]  [FULLTEXT]


[Table - 1], [Table - 2], [Table - 3]

This article has been cited by
1 Anti-seizure medications and quality of life in person with epilepsy
Rekha Dwivedi, Prabhakar Tiwari, Monika Pahuja, Rima Dada, Manjari Tripathi
Heliyon. 2022; 8(10): e11073
[Pubmed] | [DOI]
2 Quality of life in patients with symptomatic epilepsy due to neurocysticercosis
Willy R. Zapata, Susan Y. Yang, Javier A. Bustos, Isidro Gonzales, Herbert Saavedra, Carolina Guzman, E. Javier Pretell, Hector H. Garcia
Epilepsy & Behavior. 2022; 131: 108668
[Pubmed] | [DOI]
3 Sociodemographic Factors Influencing Health Care–Seeking Behavior for Pediatric Epilepsy in Southeast Nigeria
Wilson C. Igwe, Esther N. Umeadi, Sylvia T. Echendu, Amalachukwu O. Odita
Journal of Neurosciences in Rural Practice. 2022;
[Pubmed] | [DOI]
4 Gender differences in health-related quality of life of patients with active epilepsy and clinical factors that are signs of their associations: a retrospective cross-sectional study
[Pubmed] | [DOI]
5 Prospective Study of a Multimodal Convulsive Seizure Detection Wearable System on Pediatric and Adult Patients in the Epilepsy Monitoring Unit
Francesco Onorati, Giulia Regalia, Chiara Caborni, W. Curt LaFrance, Andrew S. Blum, Jonathan Bidwell, Paola De Liso, Rima El Atrache, Tobias Loddenkemper, Fatemeh Mohammadpour-Touserkani, Rani A. Sarkis, Daniel Friedman, Jay Jeschke, Rosalind Picard
Frontiers in Neurology. 2021; 12
[Pubmed] | [DOI]
6 Community pharmacists’ role in caring for people living with epilepsy: A scoping review
Jennifer L. Bacci, Sabra Zaraa, Andy Stergachis, Grant Simic, H. Steve White
Epilepsy & Behavior. 2021; 117: 107850
[Pubmed] | [DOI]
7 Association between antiseizure medications and quality of life in epilepsy: A mediation analysis
Meng Wang, Kevin Perera, Colin B. Josephson, Mubasiru Lamidi, Oluwaseyi A. Lawal, Oluwagbohunmi Awosoga, Pamela Roach, Scott B. Patten, Samuel Wiebe, Tolulope T. Sajobi
Epilepsia. 2021;
[Pubmed] | [DOI]
8 Quality of life and stigma in Lebanese people with epilepsy taking medication
Lara Mroueh, Farid Boumediene, Jeremy Jost, Voa Ratsimbazafy, Pierre-Marie Preux, Pascale Salameh, Amal Al-Hajje
Epilepsy Research. 2020; 167: 106437
[Pubmed] | [DOI]
9 Quality of life and its association with comorbidities and adverse events from antiepileptic medications: Online survey of patients with epilepsy in Australia
Jeremy M. Welton, Christine Walker, Kate Riney, Alvin Ng, Lisa Todd, Wendyl J. D'Souza
Epilepsy & Behavior. 2020; 104: 106856
[Pubmed] | [DOI]
10 Assessment of Quality of Life of Epileptic Patients in Ethiopia
Esileman Abdela Muche, Mohammed Biset Ayalew, Ousman Abubeker Abdela
International Journal of Chronic Diseases. 2020; 2020: 1
[Pubmed] | [DOI]
11 A comparative assessment of health-related quality of life in people with epilepsy and healthy controls in a tertiary hospital in Northwest Nigeria
EmmanuelUzodinma Iwuozo, ReginaldOnyeadumarakwe Obiako, Adesola Ogunniyi, SaniAuta Abubakar
Sahel Medical Journal. 2020; 23(4): 215
[Pubmed] | [DOI]
12 Health-related quality of life and its determinants among ambulatory patients with epilepsy at Ambo General Hospital, Ethiopia: Using WHOQOL-BREF
Gosaye Mekonen Tefera, Worku Asefa Megersa, Diriba Alemayehu Gadisa, Amir H. Pakpour
PLOS ONE. 2020; 15(1): e0227858
[Pubmed] | [DOI]
13 Anti-Epileptic Drug Prescription in a Psychiatric Hospital Outpatient Clinic in Southeast Nigeria
Justin U. Achor,Emeka C. Nwefoh,Birinus A. Ezeala-Adikaibe,Chinwe F. S. Ezeruigbo,Aham O. Agomoh
Open Journal of Psychiatry. 2017; 07(04): 294
[Pubmed] | [DOI]
14 Quality of Life in Patients with Epilepsy: Study from a Northern Indian Teaching Hospital
RK Sureka, Kuldeep S Yadav, Rishika Agrawal, Madhu Nijhawan
Journal of Mahatma Gandhi University of Medical Sciences and Technology. 2017; 2(1): 10
[Pubmed] | [DOI]
15 Health related quality of life in patients with epilepsy in Turkey
Fatma Karantay Mutluay,Aysegul Gunduz,Anil Tekeoglu,Semra Oguz,Seher Naz Yeni
Journal of Physical Therapy Science. 2016; 28(1): 240
[Pubmed] | [DOI]
16 Algorithms of mono- and polytherapy in clinical epileptology
V. A. Karlov,A. B. Guekht,V. I. Guzeva,L. V. Lipatova,S. N. Bazilevich,V. R. Mkrtchyan,P. N. Vlasov,I. A. Zhidkova,K. Yu. Mukhin,A. S. Petrukhin,A. V. Lebedeva
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2016; 116(7): 120
[Pubmed] | [DOI]
17 Quality of life in epilepsy—31 inventory (QOLIE-31) scores: A global comparison
Altaf Saadi,Bryan Patenaude,Farrah J. Mateen
Epilepsy & Behavior. 2016; 65: 13
[Pubmed] | [DOI]
18 Quality of life in epilepsy in Bhutan
Altaf Saadi,Bryan Patenaude,Damber Kumar Nirola,Sonam Deki,Lhab Tshering,Sarah Clark,Lance Shaull,Tali Sorets,Guenther Fink,Farrah Mateen
Seizure. 2016; 39: 44
[Pubmed] | [DOI]
19 Antiepileptic Drugs and Quality of Life in Patients with Epilepsy: A Tertiary Care Hospital-Based Study
Jesso George,Chanda Kulkarni,G.R.K. Sarma
Value in Health Regional Issues. 2015; 6: 1
[Pubmed] | [DOI]
20 Efficacy and Safety of Levetiracetam and Carbamazepine as Monotherapy in Partial Seizures
Swaroop Hassan Suresh,Ananya Chakraborty,Akash Virupakshaiah,Nithin Kumar
Epilepsy Research and Treatment. 2015; 2015: 1
[Pubmed] | [DOI]
21 Assessment of quality of life in Indian adults with epilepsy and their caregivers
Man Mohan Mehndiratta,Anwar Alam,Sanjay Pandey,Ekta Singh
International Journal of Epilepsy. 2015; 2(1): 11
[Pubmed] | [DOI]
22 Adverse events of placebo-treated, drug-resistant, focal epileptic patients in randomized controlled trials: a systematic review
Gaetano Zaccara,Fabio Giovannelli,Massimo Cincotta,Giulia Loiacono,Alberto Verrotti
Journal of Neurology. 2015; 262(3): 501
[Pubmed] | [DOI]
23 Factors Associated with Seizure Recurrence in Epilepsy Patients Treated with Antiepileptic Monotherapy: A Retrospective Observational Cohort Study using US Administrative Insurance Claims
Natalia Shcherbakova,Karen Rascati,Carolyn Brown,Kenneth Lawson,Suzanne Novak,Kristin M. Richards,Linda Yoder
CNS Drugs. 2014; 28(11): 1047
[Pubmed] | [DOI]
24 Knowledge, attitude and practice of parents regarding pediatric antiepileptic drug therapy
Minumaria Shaju,Kollencheri Puthenveettil Vinayan,Suja Abraham
International Journal of Epilepsy. 2014; 1(2): 57
[Pubmed] | [DOI]
25 Health-related quality of life in epilepsy patients receiving anti-epileptic drugs at National Referral Hospitals in Uganda: a cross-sectional study
Anne M Nabukenya,Joseph KB Matovu,Fred Wabwire-Mangen,Rhoda K Wanyenze,Fredrick Makumbi
Health and Quality of Life Outcomes. 2014; 12(1): 49
[Pubmed] | [DOI]
26 Treatment Expenditure Pattern of Epileptic Patients: A Study from a Tertiary Care Hospital, Kolkata, India
Abhik Sinha,Dulal K. Bhaumik
Neurology Research International. 2014; 2014: 1
[Pubmed] | [DOI]
27 Assessment and comparison of health-related quality-of-life (HRQOL) in patients with epilepsy in India
P.M. Jadhav,N.K. Bodke,D.A. Sanap,N.J. Gogtay
Epilepsy & Behavior. 2013; 27(1): 165
[Pubmed] | [DOI]
28 Validation of a Chinese version of the Quality of Well-Being Scale-Self-Administered (QWB-SA) in patients with epilepsy
Lan Gao,Li Xia,Song-Qing Pan,Tao Xiong,Shu-Chuen Li
Epilepsia. 2013; 54(9): 1647
[Pubmed] | [DOI]
29 Assessment of quality of life of patients with epilepsy in the neurology OPD of a tertiary care University hospital
Vanitha Rani, N. and Varughese, N.A. and Shankar, V. and Kannan, G. and Thennarasu, P.
International Journal of Research in Pharmaceutical Sciences. 2013; 4(2): 141-145
30 Assessment and comparison of health-related quality-of-life (HRQOL) in patients with epilepsy in India
Jadhav, P.M. and Bodke, N.K. and Sanap, D.A. and Gogtay, N.J.
Epilepsy and Behavior. 2013; 27(1): 165-168
31 Combination therapy for epilepsy [Kombinationstherapie bei Epilepsie]
Fröscher, W. and Rösche, J.
Fortschritte der Neurologie Psychiatrie. 2013; 81(1): 9-20
32 Medication management of adult patients admitted to hospital with epilepsy, seizure or convulsion
Walker, M.P. and Mcgovern, T.L. and Hattingh, L.H. and Hall, T.D.
Journal of Pharmacy Practice and Research. 2012; 42(4): 291-295
33 Medication Management of Adult Patients Admitted to Hospital with Epilepsy, Seizure or Convulsion
Monique P Walker,Trudy L McGovern,Laetitia H Hattingh,Tony D Hall
Journal of Pharmacy Practice and Research. 2012; 42(4): 291
[Pubmed] | [DOI]
34 Importance of some clinical factors (epilepsy duration, clusters of seizures and/or epileptic status, type of epilepsy, type of seizures, mono-/polytherapy) for the quality of life of patients with refractory epilepsy
Viteva, E.
Acta Medica Bulgarica. 2012; 39(2): 89-96
35 Self reported adverse effects of mono and polytherapy for epilepsy
Tom Andrew,Kristijonas Milinis,Gus Baker,Udo Wieshmann
Seizure. 2012; 21(8): 610
[Pubmed] | [DOI]
36 Self reported adverse effects of mono and polytherapy for epilepsy
Andrew, T. and Milinis, K. and Baker, G. and Wieshmann, U.
Seizure. 2012; 21(8): 610-613
37 Quality of life among people with epilepsy: A cross-sectional study from rural southern India
Rakesh, P.S. and Ramesh, R. and Rachel, P. and Chanda, R. and Satish, N. and Mohan, V.R.
National Medical Journal of India. 2012; 25(5): 261-264
38 Factors associated with knowledge and attitudes in persons with epilepsy
Saengsuwan, J. and Boonyaleepan, S. and Srijakkot, J. and Sawanyawisuth, K. and Tiamkao, S.
Epilepsy and Behavior. 2012; 24(1): 23-29
39 Role of pharmacists in the management of patients with epilepsy
Koshy, S.
International Journal of Pharmacy Practice. 2012; 20(1): 65-68
40 Healthcare-seeking behavior of patients with epileptic seizure disorders attending a tertiary care hospital, Kolkata
Sinha, A. and Mallik, S. and Sanyal, D. and Sengupta, P. and Dasgupta, S.
Indian Journal of Community Medicine. 2012; 37(1): 25-29
41 Factors associated with knowledge and attitudes in persons with epilepsy
Jiamjit Saengsuwan,Suwanna Boonyaleepan,Jitpinan Srijakkot,Kittisak Sawanyawisuth,Somsak Tiamkao
Epilepsy & Behavior. 2012; 24(1): 23
[Pubmed] | [DOI]
42 Determinants of quality of life in people with epilepsy and their gender differences
Li Yue, Pei-min Yu, De-hao Zhao, Dong-yan Wu, Guo-xing Zhu, Xun-yi Wu, Zhen Hong
Epilepsy & Behavior. 2011;
[VIEW] | [DOI]
43 Predictors of health-related quality of life and costs in adults with epilepsy: A systematic review
Rod S. Taylor,Josemir W. Sander,Rebecca J. Taylor,Gus A. Baker
Epilepsia. 2011; 52(12): 2168
[Pubmed] | [DOI]
44 Role of pharmacists in the management of patients with epilepsy : Management of patients with epilepsy
Samuel Koshy
International Journal of Pharmacy Practice. 2011; : no
[VIEW] | [DOI]
45 Predictors of health-related quality of life and costs in adults with epilepsy: A systematic review
Taylor, R.S. and Sander, J.W. and Taylor, R.J. and Baker, G.A.
Epilepsia. 2011; 52(12): 2168-2180
46 A comprehensive review of the literature on epilepsy in selected countries in emerging markets
Angalakuditi, M. and Angalakuditi, N.
Neuropsychiatric Disease and Treatment. 2011; 7(1): 585-597
47 Quality of life in children with epilepsy
Nadkarni, J. and Jain, A. and Dwivedi, R.
Annals of Indian Academy of Neurology. 2011; 14(4): 279-282
48 Quality of life in patients with epilepsy in India
Shetty, P.H. and Naik, R.K. and Saroja, A.O. and Punith, K.
Journal of Neurosciences in Rural Practice. 2011; 2(1): 33-38
49 Factors associated with quality of life of patients with epilepsy attending a tertiary care hospital in Kolkata, India
Sinha, A., Sanyal, D., Mallik, S., Sengupta, P., Dasgupta, S.
Neurology Asia. 2011; 16(1): 33-37
50 Assessment of health-related quality of life and influencing factors using QOLIE-31 in Japanese patients with epilepsy
Kubota, H., Awaya, Y.
Epilepsy and Behavior. 2010; 18(4): 381-387
51 Depressive symptoms in patients with epilepsy: Analysis of self-rating and physicianæs assessment
Ogunrin, O.A., Obiabo, Y.O.
Neurology India. 2010; 58(4): 565-570
52 Factors associated with quality of life in epileptics and the variations between men and women, younger and older people
Yue, L. and Yu, P.-M. and Zhao, D.-H. and Wu, D.-Y. and Wu, X.-Y. and Zhu, G.-X. and Hong, Z.
National Medical Journal of China. 2010; 90(23): 1597-1601
53 Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy
Maria Paola Canevini, Giovambattista De Sarro, Carlo Andrea Galimberti, Giuliana Gatti, Laura Licchetta, Ambra Malerba, Giancarlo Muscas, Angela La Neve, Pasquale Striano, Emilio Perucca
Epilepsia. 2010; 51(5): 797-804
[Pubmed] | [DOI]
54 Assessment of health-related quality of life and influencing factors using QOLIE-31 in Japanese patients with epilepsy
Hidemoto Kubota, Yutaka Awaya
Epilepsy & Behavior. 2010; 18(4): 381
[VIEW] | [DOI]
55 Stigma and health-related quality of life in Asian adults with epilepsy
Lim, Y.-J., Chan, S.-Y., Ko, Y.
Epilepsy Research. 2009; 87(2-3): 107-119
56 Antiepileptic drug monotherapy: The initial approach in epilepsy management
St. Louis, E.K., Rosenfeld, W.E., Bramley, T.
Current Neuropharmacology. 2009; 7(2): 77-82
57 Truly "rational" polytherapy: Maximizing efficacy and minimizing drug interactions, drug load, and adverse effects
St. Louis, E.K.
Current Neuropharmacology. 2009; 7(2): 96-105
58 Quality of life in epileptic patients in southern Thailand
Phabphal, K., Geater, A., Limapichart, K., Satirapunya, P., Setthawatcharawanich, S.
Journal of the Medical Association of Thailand. 2009; 92(6): 762-769
59 Stigma and health-related quality of life in Asian adults with epilepsy
Yi-Jing Lim,Sui-Yung Chan,Yu Ko
Epilepsy Research. 2009; 87(2-3): 107
[Pubmed] | [DOI]
60 Association of demographic, clinical and treatment variables with quality of life of patients with epilepsy in Greece
Quality of Life Research. 2008; 17(7): 987-996
[Pubmed] | [DOI]
61 Psychosocial impact of epilepsy in women of childbearing age in India
Sachin, S., Padma, M.V., Bhatia, R., Prasad, K., Gureshkumar, C., Tripathi, M.
Epileptic Disorders. 2008; 10(4): 282-289
62 Eleven influential factors for quality of life in adults with epilepsy
Wang, T.G., Wang, H., Cheng, J.H.
Neural Regeneration Research. 2008; 3(4): 422-426
63 Validation of the Spanish version of the QOLIE-10 quality of life in epilepsy questionnaire | [Validación de la versión española del cuestionario de calidad de vida en epilepsia QOLIE-10]
Viteri, C., Codina, M., Cobaleda, S., Lahuerta, J., Barriga, J., Barrera, S., Morales, M.D.
Neurologia. 2008; 23(3): 157-167
64 Epilepsy: Quality of life and assessment scale evaluation
Hu, F., Zou, X.
Neural Regeneration Research. 2008; 3(1): 83-88
65 Psychometric properties of Bengali version of QOLIE-10 in epileptic patients
Basu, S., Sanyal, D., Ghosal, M., Roy, B., Senapati, A., Das, S.
Annals of Indian Academy of Neurology. 2008; 11(1): 28-32
66 Anti epileptic drug usage and withdrawal in elderly persons with epilepsy
Jacob, N., Thomas, S.V., Sarma, P.S.
Annals of Indian Academy of Neurology. 2007; 10(1): 34-38
67 Epidemiology, aetiology, and clinical management of epilepsy in Asia: a systematic review
Tu Luong Mac, Duc-Si Tran, Fabrice Quet, Peter Odermatt, Pierre-Marie Preux, Chong Tin Tan
The Lancet Neurology. 2007; 6(6): 533-543
[Pubmed] | [DOI]


Print this article  Email this article
Previous article Next article
Online since 20th March '04
Published by Wolters Kluwer - Medknow